Pmv Pharmaceuticals Stock Performance
| PMVP Stock | USD 1.11 0.03 2.78% |
The company holds a Beta of 0.71, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Pmv Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Pmv Pharmaceuticals is expected to be smaller as well. At this point, Pmv Pharmaceuticals has a negative expected return of -0.32%. Please make sure to check Pmv Pharmaceuticals' value at risk and rate of daily change , to decide if Pmv Pharmaceuticals performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Pmv Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in March 2026. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors. ...more
1 | Why PMV Pharmaceuticals Inc. stock is a must watch in 2025 - Trade Risk Summary Safe Entry Zone Identification - newser.com | 11/21/2025 |
2 | PMV Pharmaceuticals Trading Down 1.7 percent - Heres Why - MarketBeat | 12/08/2025 |
3 | How resilient is PMV Pharmaceuticals Inc stock in market downturns - Rate Hike Weekly High Conviction Trade Ideas - moha.gov.vn | 12/26/2025 |
4 | Will PMV Pharmaceuticals Inc. stock see insider buying - Market Sentiment Report Technical Pattern Based Buy Signals - ulpravda.ru | 01/08/2026 |
5 | Fed Meeting How PMV Pharmaceuticals Inc stock reacts to oil prices - July 2025 Summary Risk Managed Trade Strategies - moha.gov.vn | 01/13/2026 |
6 | Will PMV Pharmaceuticals Spend Its Cash Wisely | 01/28/2026 |
| Begin Period Cash Flow | 38.5 M | |
| Total Cashflows From Investing Activities | 53.4 M | |
| Free Cash Flow | -51.9 M |
Pmv Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 140.00 in Pmv Pharmaceuticals on November 18, 2025 and sell it today you would lose (29.00) from holding Pmv Pharmaceuticals or give up 20.71% of portfolio value over 90 days. Pmv Pharmaceuticals is currently does not generate positive expected returns and assumes 3.2523% risk (volatility on return distribution) over the 90 days horizon. In different words, 29% of stocks are less volatile than Pmv, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Pmv Pharmaceuticals Target Price Odds to finish over Current Price
The tendency of Pmv Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.11 | 90 days | 1.11 | about 84.55 |
Based on a normal probability distribution, the odds of Pmv Pharmaceuticals to move above the current price in 90 days from now is about 84.55 (This Pmv Pharmaceuticals probability density function shows the probability of Pmv Stock to fall within a particular range of prices over 90 days) .
Pmv Pharmaceuticals Price Density |
| Price |
Predictive Modules for Pmv Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Pmv Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pmv Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Pmv Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Pmv Pharmaceuticals is not an exception. The market had few large corrections towards the Pmv Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Pmv Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Pmv Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.24 | |
β | Beta against Dow Jones | 0.71 | |
σ | Overall volatility | 0.1 | |
Ir | Information ratio | -0.08 |
Pmv Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Pmv Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Pmv Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Pmv Pharmaceuticals generated a negative expected return over the last 90 days | |
| Pmv Pharmaceuticals may become a speculative penny stock | |
| Pmv Pharmaceuticals has high historical volatility and very poor performance | |
| Net Loss for the year was (58.71 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Pmv Pharmaceuticals currently holds about 277.43 M in cash with (51.28 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.08, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Pmv Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Roughly 69.0% of the company shares are owned by institutional investors | |
| Latest headline from simplywall.st: Will PMV Pharmaceuticals Spend Its Cash Wisely |
Pmv Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Pmv Stock often depends not only on the future outlook of the current and potential Pmv Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pmv Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 51.6 M | |
| Cash And Short Term Investments | 169.5 M |
Pmv Pharmaceuticals Fundamentals Growth
Pmv Stock prices reflect investors' perceptions of the future prospects and financial health of Pmv Pharmaceuticals, and Pmv Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Pmv Stock performance.
| Return On Equity | -0.52 | ||||
| Return On Asset | -0.32 | ||||
| Current Valuation | (68.99 M) | ||||
| Shares Outstanding | 53.21 M | ||||
| Price To Book | 0.49 X | ||||
| EBITDA | (73.67 M) | ||||
| Net Income | (58.71 M) | ||||
| Cash And Equivalents | 277.43 M | ||||
| Cash Per Share | 6.08 X | ||||
| Total Debt | 1.19 M | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 24.76 X | ||||
| Book Value Per Share | 2.28 X | ||||
| Cash Flow From Operations | (51.28 M) | ||||
| Earnings Per Share | (1.59) X | ||||
| Market Capitalization | 59.06 M | ||||
| Total Asset | 191.29 M | ||||
| Retained Earnings | (368.71 M) | ||||
| Working Capital | 161.29 M | ||||
About Pmv Pharmaceuticals Performance
Assessing Pmv Pharmaceuticals' fundamental ratios provides investors with valuable insights into Pmv Pharmaceuticals' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Pmv Pharmaceuticals is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.35) | (0.37) | |
| Return On Capital Employed | (0.56) | (0.58) | |
| Return On Assets | (0.35) | (0.37) | |
| Return On Equity | (0.38) | (0.36) |
Things to note about Pmv Pharmaceuticals performance evaluation
Checking the ongoing alerts about Pmv Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Pmv Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Pmv Pharmaceuticals generated a negative expected return over the last 90 days | |
| Pmv Pharmaceuticals may become a speculative penny stock | |
| Pmv Pharmaceuticals has high historical volatility and very poor performance | |
| Net Loss for the year was (58.71 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Pmv Pharmaceuticals currently holds about 277.43 M in cash with (51.28 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.08, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Pmv Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Roughly 69.0% of the company shares are owned by institutional investors | |
| Latest headline from simplywall.st: Will PMV Pharmaceuticals Spend Its Cash Wisely |
- Analyzing Pmv Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Pmv Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Pmv Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Pmv Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Pmv Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Pmv Pharmaceuticals' stock. These opinions can provide insight into Pmv Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Pmv Stock Analysis
When running Pmv Pharmaceuticals' price analysis, check to measure Pmv Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pmv Pharmaceuticals is operating at the current time. Most of Pmv Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pmv Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pmv Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pmv Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.